share_log

Industrial Alliance Initiates Coverage On NervGen Pharma with Speculative Buy Rating, Announces Price Target of $6

Industrial Alliance Initiates Coverage On NervGen Pharma with Speculative Buy Rating, Announces Price Target of $6

產業聯盟以投機性買入評級啟動對NervGen Pharma的覆蓋,宣佈目標價為6美元
Benzinga Real-time News ·  2021/07/13 08:55

Industrial Alliance initiates coverage on NervGen Pharma (OTC:NGENF) with a Speculative Buy rating and announces Price Target of $6.

工業聯盟以投機性買入評級啟動對NervGen Pharma(場外交易代碼:NGENF)的保險,並宣佈目標價為6美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論